---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-004190"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T03:48:08.372957+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# PharmaCyte Biotech sets 2022 Annual Meeting for Aug 25; proposals due June 24

## Summary
- 2022 Annual Meeting of Stockholders scheduled for August 25, 2022.
- Stockholder proposals and director nominations must be delivered by June 24, 2022.
- Meeting date is more than 30 days from the 2021 annual meeting anniversary.

## SEC filing metadata
- accession: 0001683168-22-004190
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316822004190/0001683168-22-004190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822004190/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-004190
- JSON: https://secwatch.observer/filing/0001683168-22-004190.json
- Plain text: https://secwatch.observer/filing/0001683168-22-004190.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.